BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7589337)

  • 1. Presenting features, natural history, and prognostic factors in localized non-Hodgkin's lymphomas: analysis of 117 cases from a single institution.
    Esteve J; López-Guillermo A; Martínez-Francés A; Bosch F; Terol MJ; Campo E; Montserrat E; Rozman C
    Eur J Haematol; 1995 Oct; 55(4):217-22. PubMed ID: 7589337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
    Oguchi M; Ikeda H; Isobe K; Hirota S; Hasegawa M; Nakamura K; Sasai K; Hayabuchi N
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):161-8. PubMed ID: 10924986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma.
    López-Guillermo A; Montserrat E; Bosch F; Terol MJ; Campo E; Rozman C
    J Clin Oncol; 1994 Jul; 12(7):1343-8. PubMed ID: 8021724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.
    Cowan RA; Jones M; Harris M; Steward WP; Radford JA; Wagstaff J; Deakin DP; Crowther D
    Br J Cancer; 1989 Feb; 59(2):276-82. PubMed ID: 2930692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-Hodgkin's lymphomas. II. Analysis of the prognostic factors in a series of 307 patients].
    García Zueco JC; Delgado MP; Giraldo MP; Perella M; Rubio-Félix D; Giralt M
    Sangre (Barc); 1992 Oct; 37(5):337-44. PubMed ID: 1293772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CEOP-B alternated with VIMB in intermediate-grade and high-grade non-Hodgkin's lymphoma: a pilot study.
    De Lena M; Ditonno P; Lorusso V; Brandi M; Timurian A; Marzullo F; Ventrella V; Pellecchia A
    J Clin Oncol; 1995 Apr; 13(4):953-60. PubMed ID: 7535844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma.
    Kamath SS; Marcus RB; Lynch JW; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):563-8. PubMed ID: 10348285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
    Coiffier B; Gisselbrecht C; Vose JM; Tilly H; Herbrecht R; Bosly A; Armitage JO
    J Clin Oncol; 1991 Feb; 9(2):211-9. PubMed ID: 1703226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic features and prognostic factors of primary extranodal non-Hodgkin's lymphomas in Turkey.
    Arican A; Dinçol D; Akbulut H; Onur H; Demirkazik A; Cay F; Içli F
    Am J Clin Oncol; 1999 Dec; 22(6):587-92. PubMed ID: 10597743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphomas.
    Esik O; Ikeda H; Mukai K; Kaneko A
    Radiother Oncol; 1996 Jan; 38(1):13-8. PubMed ID: 8850421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary intestinal lymphoma: clinical and therapeutic features of 32 patients.
    Zinzani PL; Magagnoli M; Pagliani G; Bendandi M; Gherlinzoni F; Merla E; Salvucci M; Tura S
    Haematologica; 1997; 82(3):305-8. PubMed ID: 9234576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
    Joensuu H; Ristamäki R; Söderström KO; Jalkanen S
    J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors in low-grade lymphoma].
    Gandarillas MA; Conde E; Mazorra F; Cuadrado MA; Baro J; Garijo J; Recio M; Richard C; Iriondo A; Zubizarreta A
    Sangre (Barc); 1998 Jun; 43(3):185-90. PubMed ID: 9741223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group.
    d'Amore F; Brincker H; Grønbaek K; Thorling K; Pedersen M; Jensen MK; Andersen E; Pedersen NT; Mortensen LS
    J Clin Oncol; 1994 Aug; 12(8):1673-84. PubMed ID: 8040680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-Hodgkin's lymphoma in adults: a clinico-pathologic study of 169 cases].
    Ding SL; Ko WS; Hwang WS
    J Formos Med Assoc; 1990 Nov; 89(11):1017-22, 1015. PubMed ID: 1982122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma.
    McMaster ML; Greer JP; Wolff SN; Johnson DH; Greco FA; Stein RS; Cousar JB; Flexner JM; Hainsworth JD
    Cancer; 1991 Jul; 68(2):233-41. PubMed ID: 1712662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors.
    Bosch F; López-Guillermo A; Campo E; Ribera JM; Conde E; Piris MA; Vallespí T; Woessner S; Montserrat E
    Cancer; 1998 Feb; 82(3):567-75. PubMed ID: 9452276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: experience of the non-Hodgkin's Lymphoma Pathologic Classification Project.
    Simon R; Durrleman S; Hoppe RT; Bonadonna G; Bloomfield CD; Rudders RA; Cheson BD; Berard CW
    Med Pediatr Oncol; 1990; 18(2):89-96. PubMed ID: 2406556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-grade lymphoma: clinical and prognostic studies in a series of 143 patients from a single institution.
    Lopez-Guillermo A; Montserrat E; Bosch F; Escoda L; Terol MJ; Marin P; Reverter JC; Blade J; Cervantes F; Sierra J
    Leuk Lymphoma; 1994 Sep; 15(1-2):159-65. PubMed ID: 7858494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.